MEDTRONIC SELECTSECURE LEAD MODEL 3830
Medtronic Cardiac Rhythm Disease Management · Decision date Oct 16, 2026
What did the FDA decide?
Medtronic Cardiac Rhythm Disease Management received an FDA decision recorded as OK30 on 2026-10-16 for supplement S162 to PMA P030036, covering the Model 3830 SelectSecure lead, a drug-eluting permanent right ventricular or right atrial pacemaker electrode (product code NVN, cardiovascular). The supplement is a 30-day notice filed under the reason "Process Change - Manufacturer/Sterilizer/Packager/Supplier," and the stated purpose is to modify the manufacturing method for the inner assembly stringing process.
Because S162 is a supplement, P030036 remains the original approval and this notice is not a new approval of the whole system. The record identifies which process step changes—assembly of the inner assembly during stringing—but does not specify the equipment, parameter limits, validation data, or the original approved method, and the OK30 entry alone does not independently establish safety or clinical effectiveness.
FDA approval order statement
modify the manufacturing method for the inner assembly stringing process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 16, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P030036/S162
- Regulatory pathway
- PMA supplement
- Product code
- NVN
- Decision code
- OK30
- Decision date
- Oct 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Product code
- NVN
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P030036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P030036 · Original PMA
MEDTRONIC SELECTSECURE LEAD MODEL 3830
P030036/S162 received
Application receipt date recorded by FDA.
P030036/S162 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P030036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Cardiac Rhythm Disease Management | PMA approval | Aug 3, 2005 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
| ABBOTT MEDICAL | PMA approval | Jun 20, 1997 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cardiac Rhythm Disease Management
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P030036/S162
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

